Founder of Variation Biotechnologies (US), Inc. and Variation Biotechnologies, Inc. (Canada), David Evander Anderson currently is Chief Scientific Officer for VBI Vaccines, Inc. and Chief Scientific Officer at VBI Vaccines (Delaware), Inc. (a subsidiary of VBI Vaccines, Inc.).

He previously occupied the position of Vice President-Immunology & Research at Variation Biotechnologies (US), Inc., Chief Scientific Officer & Senior VP-Research at VBI Vaccines, Inc. and Assistant Professor at Harvard Medical School.

He received a doctorate from Harvard University and an undergraduate degree from the University of California, Davis.